1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc XNAS: CORT
73.00 1.59 (2.23%)
445.9K
XNAS Volume

XNAS 16 Jul, 2025 3:46 PM (EDT)

Corcept Therapeutics Inc - CORT - stock price prediction, stock price target, analyst ratings from 3 analysts

Corcept Therapeutics Inc has a share price target of US$ 138, revenue growth forecast of 33.2%, and profit growth estimate of 21.4% for FY25, based on top 3 analyst calls.